Psilocybin reduces depression severity, improves symptoms in bipolar II disorder

A single, 25 mg dose of synthetic psilocybin along with psychotherapy was safe and effective among individuals with bipolar II disorder depression, supporting further study of psychedelics for these patients, according to research.
“The 15 participants in this trial had well-documented, treatment-resistant BDII depression of marked severity and a lengthy duration of the current depressive episode,” Scott T. Aaronson, MD, of Sheppard Pratt Health System in Baltimore, and colleagues wrote in JAMA Psychiatry. “Individuals in this study displayed strong and persistent

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart
This website uses cookies and asks your personal data to enhance your browsing experience.